Gossamer Bio, Inc. (GOSS)
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi in 2015 and is headquartered in San Diego, CA.
Address
3013 SCIENCE PARK
SAN DIEGO, CA 92121
Founded
2015
Number of Employees
135
Website
http://www.gossamerbio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)